Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications measuring nutrient reduction benefits policy analysis using linked non market valuation
… than 30 years of industry and consultancy experience in market access strategies and evidence generation. Below, she … orphan drugs are disincentivised by the Inflation Reduction Act (IRA), companies might consider rebalancing … Assessment in the European Union and the Inflation Reduction Act in the United States Navigating EU Joint …
… Strategy Telecommuter - Sweden MSc, Health Economics, Policy and Management Karolinska Institutet, Stockholm, … submissions), evidence-based dossiers, health economic analysis, and systematic and targeted literature reviews. … was a Health Economist at The Dental and Pharmaceutical Benefits Agency (TLV), specialising in the evaluation of …
… the respondents and in studies recruited through online market research panels, but there was a wide range of results …
… identify themselves. They also encourage writers to avoid using loaded terms or words with a troubling history, such as … such as “Blacks” or “Whites” as nouns and instead suggest using these descriptors as adjectives: “Black people” or … similar approach applies to terms such as “mixed race” or using “Spanish” to refer to people with Latin American …
… be clearly specified in a study protocol and statistical analysis plan and should include information about the amount …
… and tailored to target audiences. Proven Strategies for Market Access Back by popular demand, this webinar will guide … is involved in creating effective GVDs. Our experts in market access strategy and outcomes strategy will share … to a variety of stakeholders and assist you in the pharma market access process. Incorporate value messages and …
… In this webinar, we’ll present the advantages of using robust health equity research methods and introduce … literature reviews and distributional cost-effectiveness analysis Review social determinants data and tools to …
… to help our clients develop strategies in the autoimmune market and to develop and gain market access for products to treat autoimmune diseases and …
… adverse event and cost trade-offs for reduced risk of non-melanoma skin cancer. Skelsey MK, Okun MM, Schiro J, …
… and patient access. Creating a strategic plan with a Market Access Evidence Roadmap can help you identify areas of … necessary for orphan drug development as we cover: Market Access Evidence Roadmaps - Their critical role in … providers, and patients. Who can benefit from early market access planning for rare disease therapies? …